Position in DCTH
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$149,092
-$535,465 QoQ
Shares Held
16,066
-76.3% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DCTH Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026GSA CAPITAL PARTNERS LLP holds $31,522,666 across 48 Medical Devices names. DCTH ranks #45 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
44,579 | $4,576,925 | |
| 2 | PRCT |
PROCEPT BioRobotics Corp
|
78,677 | $1,967,711 | |
| 3 | BSX |
Boston Scientific Corp
|
31,294 | $1,963,698 | |
| 4 | PODD |
Insulet Corp
|
7,878 | $1,653,119 | |
| 5 | NPCE |
NeuroPace Inc
|
117,672 | $1,547,386 | |
| 6 | MASS |
908 Devices Inc.
|
251,028 | $1,536,291 | |
| 7 | INFU |
InfuSystem Holdings, Inc
|
162,670 | $1,501,444 | |
| 8 | OFIX |
Orthofix Medical Inc.
|
121,226 | $1,390,462 |
All Filings in DCTH
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $149,092 | 16,066 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $684,557 | 67,778 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $933,789 | 68,661 | Shares | Sole | 2025-07-22 | |
| 2024-12-31 | $130,634 | 10,850 | Shares | Sole | 2025-02-07 | |
| 2023-09-30 | $63,139 | 15,590 | Shares | Sole | 2023-11-15 | |
| No filing history on record for this holder in this stock. | ||||||